Central Trust Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$973K Buy
11,229
+1,179
+12% +$113K 0.02% 349
2025
Q4
$965K Sell
10,050
-536
-5% -$52.1K 0.02% 346
2025
Q3
$1.01M Sell
10,586
-536
-5% -$49.3K 0.02% 332
2025
Q2
$969K Buy
11,122
+622
+6% +$52.7K 0.02% 328
2025
Q1
$944K Buy
10,500
+22
+0.2% +$1.97K 0.02% 327
2024
Q4
$837K Buy
10,478
+402
+4% +$34.8K 0.02% 342
2024
Q3
$907K Buy
10,076
+342
+4% +$28.8K 0.02% 334
2024
Q2
$766K Sell
9,734
-1,376
-12% -$113K 0.02% 349
2024
Q1
$968K Sell
11,110
-379
-3% -$32.3K 0.02% 321
2023
Q4
$946K Sell
11,489
-1,693
-13% -$129K 0.03% 324
2023
Q3
$1.03M Buy
13,182
+3,041
+30% +$255K 0.03% 304
2023
Q2
$893K Sell
10,141
-369
-4% -$31.8K 0.02% 328
2023
Q1
$847K Sell
10,510
-4,702
-31% -$383K 0.02% 330
2022
Q4
$1.18M Sell
15,212
-307
-2% -$24.9K 0.04% 273
2022
Q3
$1.25M Sell
15,519
-792
-5% -$71.2K 0.04% 262
2022
Q2
$1.46M Sell
16,311
-33
-0.2% -$3.34K 0.05% 255
2022
Q1
$1.81M Sell
16,344
-1,686
-9% -$178K 0.05% 245
2021
Q4
$1.86M Sell
18,030
-20
-0.1% -$2.32K 0.05% 254
2021
Q3
$2.26M Sell
18,050
-5,361
-23% -$694K 0.08% 211
2021
Q2
$2.91M Buy
23,411
+162
+0.7% +$20.3K 0.11% 174
2021
Q1
$2.75M Sell
23,249
-146
-0.6% -$17.1K 0.11% 165
2020
Q4
$2.74M Sell
23,395
-957
-4% -$105K 0.11% 150
2020
Q3
$2.53M Sell
24,352
-367
-1% -$36.9K 0.11% 143
2020
Q2
$2.27M Sell
24,719
-1,926
-7% -$185K 0.11% 147
2020
Q1
$2.4M Sell
26,645
-1,522
-5% -$162K 0.15% 133
2019
Q4
$3.2M Buy
28,167
+30
+0.1% +$3.29K 0.16% 125
2019
Q3
$3.06M Sell
28,137
-46
-0.2% -$4.8K 0.17% 125
2019
Q2
$2.82M Sell
28,183
-4,251
-13% -$388K 0.16% 133
2019
Q1
$2.95M Buy
32,434
+1,645
+5% +$147K 0.18% 127
2018
Q4
$2.8M Buy
30,789
+6,380
+26% +$596K 0.19% 118
2018
Q3
$2.4M Buy
24,409
+755
+3% +$69.8K 0.14% 146
2018
Q2
$2.02M Sell
23,654
-275
-1% -$23K 0.13% 157
2018
Q1
$1.92M Sell
23,929
-2,385
-9% -$197K 0.12% 164
2017
Q4
$2.13M Sell
26,314
-414
-2% -$33.2K 0.13% 154
2017
Q3
$2.08M Sell
26,728
-1,448
-5% -$120K 0.13% 154
2017
Q2
$2.5M Sell
28,176
-8,417
-23% -$710K 0.17% 136
2017
Q1
$2.95M Sell
36,593
-7,283
-17% -$569K 0.2% 119
2016
Q4
$3.13M Sell
43,876
-35,964
-45% -$2.83M 0.22% 121
2016
Q3
$6.9M Sell
79,840
-3,131
-4% -$273K 0.5% 53
2016
Q2
$7.2M Sell
82,971
-78
-0.1% -$6.31K 0.54% 47
2016
Q1
$6.23M Sell
83,049
-996
-1% -$75K 0.49% 54
2015
Q4
$6.46M Sell
84,045
-2,454
-3% -$185K 0.53% 50
2015
Q3
$5.79M Buy
86,499
+5,383
+7% +$396K 0.5% 53
2015
Q2
$6.01M Buy
81,116
+3,437
+4% +$263K 0.47% 55
2015
Q1
$6.06M Buy
77,679
+18,949
+32% +$1.44M 0.49% 51
2014
Q4
$4.24M Buy
58,730
+14,203
+32% +$987K 0.35% 77
2014
Q3
$2.76M Buy
44,527
+251
+0.6% +$16K 0.22% 110
2014
Q2
$2.82M Buy
44,276
+12,512
+39% +$760K 0.22% 110
2014
Q1
$1.96M Sell
31,764
-7,090
-18% -$413K 0.16% 142
2013
Q4
$2.23M Sell
38,854
-502
-1% -$28.5K 0.19% 124
2013
Q3
$2.1M Buy
39,356
+1,703
+5% +$91.6K 0.19% 121
2013
Q2
$1.94M Buy
+37,653
New +$1.86M 0.18% 120

Other funds holding MDT

Central Trust Company's MDT Position: Q1 2026 in Review

Central Trust Company increased its Medtronic (MDT) stake by 12% in Q1 2026, buying an estimated $113K and bringing the position to 11,229 shares worth $973K. The position accounts for 0.02% of the portfolio, ranked #349.

Central Trust Company first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.2M in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Central Trust Company held 11,229 shares of Medtronic worth $973K as of Q1 2026.
  • Central Trust Company bought 1,179 Medtronic shares in Q1 2026, an estimated $113K.
  • Medtronic made up 0.02% of Central Trust Company's portfolio in Q1 2026, its #349 holding.
  • Central Trust Company first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's Medtronic position peaked at $7.2M in Q2 2016.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.